Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2

Chemotherapy-induced peripheral neuropathy (CIPN) is a major drawback in the use of chemotherapeutic agents for patients with cancer. Although studies have investigated a broad number of molecules that might be related to CIPN, the differences in the chemokine pathways between various chemotherapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hee Seong, Choi, Young In, Park, Seon Uk, Han, Yi Seul, Kwon, Jean, Jung, Sung Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915321/
https://www.ncbi.nlm.nih.gov/pubmed/36768178
http://dx.doi.org/10.3390/ijms24031855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915321/
https://www.ncbi.nlm.nih.gov/pubmed/36768178
http://dx.doi.org/10.3390/ijms24031855

Ejemplares similares